Advertisement

Mobile Banner
Mobile Banner
Mobile Banner
Loading...

Psyence Group Inc.

PSYGF•PNK
Healthcare
Drug Manufacturers - General
$0.13
$-0.01(-8.90%)
U.S. Market opens in 5h 7m

Psyence Group Inc. (PSYGF) Stock Overview

Explore Psyence Group Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap2M
P/E Ratio-0.17
EPS (TTM)$-0.74
ROE3.04%
Fundamental Analysis

AI Price Forecasts

1 Month$0.14
3 Months$0.18
1 Year Target$0.21

PSYGF Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Psyence Group Inc. (PSYGF) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 48.15, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $0.21.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -0.17 and a market capitalization of 2M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-8.90%
5-Day Change
N/A
1-Month Change
N/A
3-Month Change
N/A
6-Month Change
9.01%
Year-to-Date (YTD) Change
N/A
1-Year Change
12.89%
3-Year Change
-92.74%
5-Year Change
-83.55%
All-Time (Max) Change
-83.55%

Contact Information

https://www.psyence.com
NaN
200 Bay Street, Toronto, ON, M5J 2J1

Company Facts

IPO DateMay 31, 2022
CountryCA
Actively Trading

Frequently Asked Questions